Real-time enrollment status for this untreated advanced or metastatic gastric, gastroesophageal junction , or esophageal adenocarcinoma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:49 AM UTC
| NCT Number | NCT07392892 |
| Recruiting Status | Recruiting |
| Condition | Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal Adenocarcinoma |
| Phase | Clinical Trial |
| Target Enrollment | 840 participants |
| Active Locations | 61 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | June 12, 2026 (Jun 12, 2026) |
As of July 13, 2026: Clinical trial NCT07392892 is currently recruiting participants. This clinical trial study for untreated advanced or metastatic gastric, gastroesophageal junction , or esophageal adenocarcinoma is actively seeking new participants at 61 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07392892 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 61 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07392892 was last updated Jun 12, 2026 (June 12, 2026). HelloStudys verifies this status automatically.